Favourable Outcome of a Pregnancy with a Maraviroc-Containing Regimen
| Autor: | Ahmed Tigazin, Vincent Jeantils, Anabela Rodrigues, Eric Lachassine, Gilles Peytavin, Michelle Bentata |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Pregnancy
Pediatrics medicine.medical_specialty business.industry Immunology Transplacental Dermatology medicine.disease Raltegravir Emtricitabine Regimen chemistry.chemical_compound Infectious Diseases Acquired immunodeficiency syndrome (AIDS) chemistry Virology medicine business Developed country medicine.drug Maraviroc |
| Zdroj: | Journal of AIDS & Clinical Research. |
| ISSN: | 2155-6113 |
| Popis: | In developed countries, recommendations do exist concerning the use of highly active antiretroviral therapy during pregnancy of HIV positive women. The choice is easy when the mother is infected with a wild virus or in case of only few genotypic mutations; when multiple genotypic resistances are present or in case of a poor adherence, the treatment choice is more difficult. Concerns exist about the use of new available drugs in pregnancy regarding transplacental passage and foetal toxicity. We report here the first case of the use of CCR5 inhibitor-containing regimen during pregnancy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|